A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria
- 9 January 1997
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 336 (2), 86-91
- https://doi.org/10.1056/nejm199701093360202
Abstract
The candidate vaccines against malaria are poorly immunogenic and thus have been ineffective in preventing infection. We developed a vaccine based on the circumsporozoite protein of Plasmodium falciparum that incorporates adjuvants selected to enhance the immune response.Keywords
This publication has 29 references indexed in Scilit:
- Long-lasting CD8 T cell memory in the absence of CD4 T cells or B cells.The Journal of Experimental Medicine, 1996
- Safety, immunogenicity and limited efficacy study of a recombinant Plasmodium falciparum circumsporozoite vaccine in Thai soldiersVaccine, 1994
- Tolerance, Danger, and the Extended FamilyAnnual Review of Immunology, 1994
- T Cell Responses to Pre-Erythrocytic Stages of Malaria: Role in Protection and Vaccine Development Against Pre-Erythrocytic StagesAnnual Review of Immunology, 1993
- Molecular analysis of the association of HLA-B53 and resistance to severe malariaNature, 1992
- A malaria T-cell epitope recognized in association with most mouse and human MHC class II moleculesNature, 1988
- Safety and immunogenicity in man of a synthetic peptide malaria vaccine against Plasmodium falciparum sporozoitesNature, 1987
- Anti-HBs Responses to Vaccination with a Human Hepatitis B Vaccine Made by Recombinant DNA Technology in YeastThe Journal of Infectious Diseases, 1986
- Immunogenicity of Synthetic Peptides from Circumsporozoite Protein of Plasmodium falciparumScience, 1985
- Circumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax.The Journal of Experimental Medicine, 1982